Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc > Over 12 Million Rapid Antigen Screening Tests Now Shipped

<< Previous

Bullboard Posts

Next >>

Comment by wm23fouron Jun 09, 2021 4:21pm

110 Views

Post# 33356973

RE:Over 12 Million Rapid Antigen Screening Tests Now Shipped

Nice to hear that 14 M rapid antigen tests being shipped. But really, what is the significance of this for Sona. How many of these are Sona tests? My guess is 0. There is no doubt in my mind that there will be significant demand for rapid testing now and also well into the future. I'm sold on that. The question many Sona investors have is, will Sona be filling any of this demand? We continue the wait to find out.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing